FPF
ISEE

FNY Partners Fund’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

FNY Partners Fund’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-3,000
Closed -$7K – 746
2017
Q2 		$7K Hold
3,000
– – ﹤0.01% 414
2017
Q1 		$10K Sell
3,000
-5,000
-63% -$21.1K ﹤0.01% 1100
2016
Q4 		$39 Buy
+8,000
New +$237K ﹤0.01% 325

Other funds holding ISEE

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

FNY Partners Fund's ISEE Position: Q3 2017 in Review

FNY Partners Fund sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2017, closing a stake of 3,000 shares — an estimated $7K sold.

FNY Partners Fund first reported a position in ISEE in Q4 2016 and held it in 3 quarters. The position peaked at $10K in Q1 2017. 67 funds tracked by Wall St. Rank hold ISEE as of Q3 2017.

  • FNY Partners Fund reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2017 after selling out during the quarter.
  • FNY Partners Fund sold 3,000 IVERIC bio, Inc. Common Stock shares in Q3 2017, an estimated $7K.
  • FNY Partners Fund first reported a position in IVERIC bio, Inc. Common Stock in Q4 2016 and held it in 3 quarters.
  • FNY Partners Fund's IVERIC bio, Inc. Common Stock position peaked at $10K in Q1 2017.
  • 67 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2017.

Based on FNY Partners Fund's 13F filing for Q3 2017, filed 9 Nov 2017.